Daxor Corporation (DXR) — Stock Score Summary

Daxor Corporation (DXR) has a MoatMap StockRank of 28/100 based on Quality (33/100), Value (40/100), and Momentum (42/100) factor scores. The current signal is SELL. Daxor Corporation is a micro-cap medical device company specializing in blood volume analyzers. It lacks the scale, liquidity, and robust financial metrics required for a concentrated global equity fund, with no connection to our active macro themes.

Daxor Corporation is a medical instrumentation and biotechnology company specializing in blood volume measurement technology. The company's competitive moat is anchored by its BVA-100 (Blood Volume Analyzer), which is the only FDA-cleared diagnostic device capable of directly and accurately measuring a patient's total blood volume. Daxor operates as a unique niche player, with its technology increasingly adopted in intensive care units to guide fluid management for heart failure and sepsis patients.

Key Financial Metrics

Price$10.00
Market Cap$58M
P/E (TTM)6.76
Price/Book1.22
Return on Equity22.5%
Gross Margin100.0%
Operating Margin-9660.6%
Revenue Growth-82.6%
Free Cash Flow$100K

Daxor Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Daxor Corporation’s (DXR) StockRank?
MoatMap’s StockRank for Daxor Corporation (DXR) is 28/100, with a Sell signal. It is a composite of Quality (33), Value (40), and Momentum (42) factor ranks across MoatMap’s 19,000+ stock universe.
Does Daxor Corporation have an economic moat?
Daxor Corporation (DXR) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Daxor Corporation a buy, hold, or sell?
MoatMap’s current signal for Daxor Corporation (DXR) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Daxor Corporation in?
Daxor Corporation (DXR) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).
Browse all ranked stocksDXR deep dive reportAI ChampionsHow we score stocksSense-check another stock